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Background: Although autism is a global disorder, relatively little is known about 
the prevalence of consanguinity among autism spectrum disorder (ASD) individuals. 
Also, the relation of ASD comorbidities (Epilepsy and Intellectual Disability) to 
consanguinity have not been explored. 
Aims: We aim to estimate the global prevalence of consanguinity among the ASD 
individuals and compare it that among different populations. In addition, we aim 
document the prevalence of epilepsy and ID in relation to consanguinity in individuals 
diagnosed with ASD in Qatar and to assess the association between epilepsy and ID 
and consanguinity and other potential socio-demographic factors, environmental and 
other clinical factors. 
Methods:  Meta-Analysis of observational studies reporting prevalence of 
consanguinity among ASD individuals from 8 countries were searched systematically 
in important databases including EMBASE, PubMed and Academic Search Complete. 
Individual studies were screened by two reviewers independently, extracted data and 
assessed the risk of bias using a risk of bias tool. Random Effect model was used to 
calculate pooled weighted estimates due to considerable heterogeneity. Subgroup 
analysis was also calculated.  
Moreover, secondary data were analyzed using the cross-sectional study on profiles 
and correlates of ASD clinical sample in Qatar. Descriptive, univariable and 
multivariable analysis were conducted to estimate the prevalence of consanguinity, 
epilepsy and ID among ASD individuals in this cohort and assess association to other 
potential confounding determinants. 
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Results: The meta-analysis included 10 studies reporting prevalence of consanguinity 
among ASD cases. The pooled estimate of consanguinity among ASD cases was 24% 
(95%CI:17%-32%). Subgroup analysis by the study country led to a higher pooled 
estimate of consanguinity of 38% (95%CI:28%-49%) in the GCC countries compared 
to other than GCC countries with a pooled estimate of 16% (95%CI:11%-23%). 
The cross-sectional included a total of 171 ASD cases. Male to female ratio 4:1 and 
mean age was 13.5 years. Epilepsy was reported by 19%. ID reported by 83% of the 
cases. 76.6% were nonverbal. Eighty-three percent of the families had one proband, 
9.9% had 2 probands, and 7.1% had more than two. The association between epilepsy 
and ID among ASD patients and consanguinity was not statistically significant (P 
value >0.05) controlling for other potential risk factors. 
Conclusion: The globally estimated pooled consanguinity prevalence among ASD 
patients was 24%, GCC countries showed a higher pooled prevalence (38%). The 
clinical sample used did not provide any evidence on association between both 
epilepsy and ID and consanguinity among ASD patients in Qatar. Further larger 
studies with much better large and representative sample may be required to confirm 











اٌخٍف١خ: ػٍٝ اٌشغُ ِٓ أْ ط١ف  اٌزٛحذ ٘ٛ اضطشاة ػبٌّٟ، إال أٔٗ ال٠ُؼشف إال اٌم١ًٍ حٛي ش١ٛع اٌمشاثخ ث١ٓ 
. وزٌه، ٌُ ٠زُ اسزىشبف اٌؼاللخ ث١ٓ األِشاع اٌّظبحجخ (ASD)اٌّشضٝ اٌّظبث١ٓ ثبضطشاة ط١ف اٌزٛحذ 
 الضطشاة ط١ف اٌزٛحذ )اٌظشع ٚاإلػبلخ اٌز١ٕ٘خ( ٚث١ٓ اٌمشاثخ.
األ٘ذاف: ٔٙذف إٌٝ رمذ٠ش ِؼذي االٔزشبس اٌؼبٌّٟ ٌٍمشاثخ ث١ٓ األطفبي اٌّظبث١ٓ ثبضطشاة ط١ف اٌزٛحذ 
ِخزٍف اٌّدّٛػبد اٌسىب١ٔخ. ثبإلضبفخ إٌٝ رٌه، ٔٙذف إٌٝ رٛث١ك ِؼذي أزشبس اٌظشع ٚاإلػبلخ  ِٚمبسٔزٗ ث١ٓ
اٌز١ٕ٘خ ف١ّب ٠زؼٍك ثبٌمشاثخ ػٕذ األطفبي اٌّشخظ١ٓ ثبضطشاة ط١ف اٌزٛحذ فٟ لطش ٚرم١١ُ االسرجبط ث١ٓ اٌظشع 
ف١خ ٚاٌج١ئ١خ اٌّحزٍّخ ٚاٌؼٛاًِ اٌسش٠ش٠خ ٚاإلػبلخ اٌز١ٕ٘خ ٚث١ٓ اٌمشاثخ ٚغ١ش٘ب ِٓ اٌؼٛاًِ االخزّبػ١خ اٌذ٠ّٛغشا
 .األخشٜ
ٌذساسبد اٌّشب٘ذح اٌزٟ رش١ش  Meta-Analysis اٌطشق: رُ إخشاء رح١ًٍ ثشىً ِٕٙدٟ ثطش٠مخ اٌزح١ًٍ اٌجؼذ
ثٍذاْ فٟ لٛاػذ اٌج١بٔبد اٌشئ١س١خ ثّب فٟ رٌه 8ٌّؼذي أزشبس اٌمشاثخ ث١ٕحبالد اضطشاة ط١ف اٌزٛحذ ضّٓ   
PubMed ٚEMBASE  ٚ  Academic Search Complete  ٚلبَ اثٕبْ ِٓ اٌّشاخؼ١ٓ ثفحض اٌذساسبد
اٌفشد٠خ ثشىً ِسزمً، ٚاسزخالص اٌج١بٔبد ٚرم١١ُ خطش االٔح١بص ثبسزخذاَ أداح خطشاالٔح١بص. ٚٔظًشا ٌؼذَ 
ً اٌزدبٔس اٌّؼزجش، رُ حسبة اٌزمذ٠شاد اٌّٛصٚٔخ ثبسزخذاَ ّٔٛرج اٌزأث١ش اٌؼشٛائٟ. وّب رُ حسبة رح١ٍ
  .اٌّدّٛػخ اٌفشػ١خ وزٌه
ػٍٝ اٌٍّفبد   cross-sectional studyػالٚح ػٍٝ رٌه، رُ رح١ًٍ اٌج١بٔبد اٌثب٠ٛٔخ ثبسزخذاَ دساسخ ِسزؼشضخ
اٌشخظ١خ ٚاالسرجبط ٌؼ١ٕخ سش٠ش٠خ الضطشاة ط١ف اٌزٛحذ فٟ لطش. ٚأخشٞ رح١ًٍ ٚطفٟ ٚ ٚح١ذ اٌّزغ١ش  
ِٚزؼذد اٌّزغ١شاد ٌزمذ٠ش ِؼذي أزشبس اٌمشثٝ ٚاٌظشع ٚاإلػبلخ اٌز١ٕ٘خ ث١ٓ األطفبي اٌّظبث١ٓ ثبضطشاة ط١ف 
ٌّحذداد اٌّشثىخ اٌّحزٍّخاٌزٛحذ ضّٓ ٘زٖ اٌدّبػخ ٚرم١١ُ االسرجبط ِغ غ١ش٘ب ِٓ ا . 
(meta-analysis) إٌزبئح : اٌزح١ًٍ اٌجؼذٞ  دساسبد حٛي ش١ٛع اٌمشاثخ ث١ٓ اٌّشضٝ  01رضّٓ دساسخ  
ٌزٛحذضطشاة ط١ف ااٌّظبث١ٓ ثبضطشاة ط١ف اٌزٛحذ. إْ رمذ٠ش ٔسجخ اٌمشاثخ ػٕذ اٌّشضٝ اٌّظبث١ٓ ثب وبٔذ  
خ أدٜ إٌٝ  ٔسجخ رمذ٠ش أػٍٝ ٌٍمشاثخ ث١ٓ ِشضٝ ط١ف اٌزٛحذ %. رح١ًٍ اٌّدّٛػخ اٌفشػ١خ ثحست ثٍذ اٌذساس42 
01ذٚي اٌخ١ٍح (ٚرٌه ثٕسجخ ٌ% فٟ دٚي اٌخ١ٍح ِمبسٔخ ثغ١ش٘ب ِٓ اٌذٚي )اٌزٟ ال رزجغ 88ثٕسجخ  .% 
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حبٌخ ِٓ ِشضٝ ط١ف اٌزٛحذ ،ٔسجخ اٌشخبي  070رضّٕذ  cross sectional study إْ اٌذساسخ اٌّسزؼشضخ
%ِٓ 09سٕخ. رُ اإلثالؽ ػٓ اإلطبثخ ثبٌظشع ثٕسجخ 08.1ي اٌؼّش اٌٛسطٟ ف١ٙب ِٚؼذ 2:0ٌٍٕسبء وبٔذ  
% ِٓ 71اٌزٛاطً اٌغ١ش ٌفظٟ وبٔذ حبالد % ِٓ اٌحبالد. وّب أْ ٔسجخ 88اٌحبالد ،ٚاإلػبلخ  اٌز١ٕ٘خ ثٕسجخ 
١َٓ.% ٌذ٠ُٙ اوثش ِٓ ِظبث7.0% ٌذ٠ُٙ ِظبث١َٓ  ٚ 9.9 % ِٓ اٌؼبئالد ٌذ٠ُٙ ِظبة ٚاحذ ،88اٌحبالد،    
 اٌؼاللخ ث١ٓ اٌظشع ٚاإلػبلخ اٌز١ٕ٘خ ث١ٓ اٌّشضٝ اٌّظبث١ٓ ثط١ف اٌزٛحذ ٚاٌمشاثخ ٌُ رىٓ رٚ أ١ّ٘خ احظبئ١خ
 .ثؼذ اٌس١طشح ػٍٟ ػٛاًِ اٌخطش األخشٜ اٌّحزٍّخ
%. دٚي 42االسسزٕزبج )إٌز١دخ(: إْ رمذ٠ش ِؼذي  االٔزشبس اٌؼبٌّٟ ٌٍمشاثخ  ث١ٓ ِشضٝ ط١ف اٌزٛحذ وبْ ثٕسجخ 
%. إْ اٌؼ١ٕخ اٌسش٠ش٠خ اٌّسزخذِخ ١ٍ88ح أظٙشد رمذ٠شاً أػٍٝ ٌٍمشاثخ ث١ٓ اٌّشضٝ اٌّظبث١ٓ ثط١ف اٌزٛحذ اٌخ
ٌٙزٖ اٌذساسخ ٌُ رمذَ أٞ د١ًٌ حٛي اٌؼاللخ ث١ٓ وً ِٓ )وال( اٌظشع ٚاإلػبلخ اٌز١ٕ٘خ ِغ اٌمشاثخ ث١ٓ ِشضٝ 
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Chapter 1: Introduction 
1.1 Background 
Autism Spectrum Disorder (ASD) or autistic disorder is a complex 
neurodevelopmental syndrome that affects  the person’s capability to socially interact 
with others, communicate and reply to stimulations in their environments (Elsabbagh 
et al., 2012). ASD is presently considered as one of the most frequent morbidities of 
childhood and presents in different levels of severity (El-Baz et al., 2016). It is has 
been estimated that out of every 1000 child, 3–6 of them would have autism 
worldwide and the prevalence is higher in males compared to females (El-Baz et al., 
2016). However, the magnitude of autism in the Gulf Cooperation Council (GCC) 
region is still unclear as epidemiological research into this area is considered to be 
relatively new (Salhia, Al-Nasser, Taher, Al-Khathaami, & El-Metwally, 2014). 
Studies have found that autism prevalence is 0.6%in the Kingdom of Saudi Arabia 
(Hemdi & Daley, 2017), 1.4% in Oman (Al-Farsi et al., 2011) and 1.1% in Qatar 
(Qatar-tribune 2018). Studies in the United Kingdom and America estimated the 
economic burden of autism to be more than several billion US dollars (Ganz, 2007; 
Knapp, Romeo, & Beecham, 2009). 
Although neonatal and prenatal risk factors were the focus of numerous 
epidemiological studies over 40 years, Autism etiology is still unknown (Gardener, 
Spiegelman, & Buka, 2011). As many risk factors were related to ASD, family history 
of ASD, high paternal and maternal age (>35years), were also related to a noteworthy 
increase in the risk of autism (El-Baz, Ismael, & El-Din, 2011). Other factors like 
exposure to lead, mercury as well as radiation has been proposed as possible causes of 
autism (El-Baz et al., 2016). A number of theories about the pathogenesis proposed 
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the interaction between different genetic predispositions and environmental factors 
(Tchaconas & Adesman, 2013). 
  One of the factors that have been linked to autism and is related to genetic is 
consanguinity. Consanguinity can be defined as the ―relation between two people who 
share a common ancestor‖ (Dahdouh, Taleb, Blecha, & Benyamina, 2016); 
constructed between individuals who are biologically related (Dahdouh et al., 2016). 
Almost 20% of the world's population lives in societies that favor consanguineous 
unions such as Northern Africa and South Asia (Dahdouh et al., 2016). In Qatar, 
consanguinity is estimated to be 54% (Bener & Hussain, 2006).  Many medical 
complications are known in consanguineous marriages such as malformations (Jaber 
et al., 2005) and rare recessive genetic disorders (Bittles, 2008), in addition to 
disorders of complex inheritance, like psychiatric disorders (Mansour et al., 2010; 
Musante & Ropers, 2014; Sharkia, Azem, Kaiyal, Zelnik, & Mahajnah, 2010).  
ASD is associated with high rates of other disorders comorbidity, for example, 
anxiety disorders, fears and phobias, mood disorders, attention deficit hyperactive 
disorder (ADHD) and epilepsy (Ghaziuddin, Ghaziuddin, & Greden, 2002; Leyfer et 
al., 2006; LoVullo & Matson, 2009; Simonoff et al., 2008; Smith & Matson, 2010a, 
2010b, 2010c). Recently, researchers started to acknowledge, and emphasis on 
comorbidity in individuals with ASD (LoVullo & Matson, 2009; Smith & Matson, 
2010c).  The co-occurrence of epilepsy and ASD is well recognized (Canitano, 2007; 
Spence & Schneider, 2009; R. Tuchman & Rapin, 2002). Epilepsy prevalence in 
persons with ASD have roughly varied between 5% to 46% (Spence & Schneider, 
2009).  Rates of ASD and comorbid ADHD differ widely, with estimates ranging 
from 14 to 78% (Amr et al., 2012; Gjevik, Eldevik, Fjæran-Granum, & Sponheim, 
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2011; Holtmann, Bölte, & Poustka, 2007). These estimations put ADHD as one of the 
most frequent comorbid disorders in individuals with ASD. 
About one third of youth with ASD had intellectual skills in the Intellectual Disability 
(ID) range as stated by the latest Centers for Disease Control and Prevention (CDC) 
report, (with additional 23 % in the marginal range), although estimations through 
studies range broadly, from 26 to 68 % (Centers for Disease Control and, 2012; 
Fombonne, 2005; Yeargin-Allsopp et al., 2003).  
With the growing worldwide prevalence of ASD, as well as in Qatar (1.4%), research 
should have rapidly progressed efforts to improved understand the increase in it is 
incidence and co morbidities. The overall prevalence of consanguinity among ASD 
patients and it is association with ASD comorbidities have not been fully explored, 
thus it is vital to investigate such association. 
1.2 Aims 
This study aims to estimate the global prevalence of consanguinity among the ASD 
individuals and compare it that among different populations (Meta-analysis). In 
addition, the aim is to document the prevalence of epilepsy and ID in relation to 
consanguinity in individuals diagnosed with ASD in Qatar and to assess the 
association between epilepsy and ID and consanguinity and other potential socio-
demographic factors, environmental and other clinical factors (Cross-sectional study). 
1.3 Research Questions 
 What is the global prevalence of consanguinity among ASD? 
 Is consanguineous marriage associated with increasing occurrence of ID and 
Epilepsy among ASD individuals in Qatar?  
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Chapter 2 Literature Review 
2.1 Autism Spectrum Disorder (ASD) 
Autism Spectrum Disorder (ASD) or autistic disorder is a complex 
neurodevelopmental syndrome that affects  the person’s capability to socially interact 
with others, communicate and reply to stimulations in their environments (Elsabbagh 
et al., 2012). Autism symptoms commonly appear in the first two years of life, but it 
can be diagnosed at any age (NIMH). There are several conditions come under autism 
spectrum disorder that can be diagnosed separately as indicated by American 
Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders 
(DSM-IV): Asperger syndrome, pervasive developmental disorder not otherwise 
specified (PDD-NOS) and autistic disorder (CDC).  In the most recent form of 
American Psychiatric Association’s Diagnostic and Statistical Manual of Mental 
Disorders (DSM 5), Autistic Disorder, Asperger’s Disorder and PDD-NOS are 
replaced by the diagnosis of Autism Spectrum Disorder (Autism Society). 
ASD can result in important communication, behavioral and social challenges. 
Individuals with ASD may behave, communicate, learn and interact in different ways 
than other people. AS ASD problem-solving, educational and thinking capabilities 
varied from talented to severely confronted, some of them need a large amount of 
assistance in their everyday lives, while others need less (CDC). 
2.2 Burden of ASD 
2.2.1 Global 
ASD is currently considered as one of the most common neurodevelopmental 
childhood disorder and presents in various degrees of severity (El-Baz et al., 2016). It 
is has been estimated that out of every 1000 child, 3–6 of them would have autism 
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worldwide and the prevalence is higher in males compared to females (El-Baz et al., 
2016). In 2012, a review comparing ASD prevalence in various parts of the world, 
researchers reported the median global prevalence as approximately 1 in 161 
(62/10,000) for all pervasive developmental disorders and 1 in 588 (17/10,000) for 
autistic disorder (Elsabbagh et al., 2012). The inconstancy between countries and 
regions and the growth in estimates over time may be related to the change in 
diagnostic criteria and approaches as well as the increasing autism awareness 
throughout the world (Elsabbagh et al., 2012). In the United Kingdom 2006, the 
prevalence of all ASDs in 9-10-year-olds children was 116.1/10,000, however, in 
2014, 1 out of every 100 children has ASD as reported by the National Autistic 
Society (Baird et al., 2006). In Brazil A pilot study was conducted and stated a 
prevalence rate of 27/10,000 (Paula, Ribeiro, Fombonne, & Mercadante, 2011); while 
in Quito and Ecuador the prevalence of ASD in schoolchildren was observed to be 
11/10,000 persons (Dekkers, Groot, Mosquera, Zúniga, & Delfos, 2015). In Canada, 
ASD rank as one of the widely recognized developmental disabilities, with a 
prevalence rate of 1.2%, in children aged 1 to 17 years in 2014 to 2015 (Diallo et al., 
2018). 
2.2.2 Asia 
Elsabbagh et al, 2012 conducted a review of the epidemiological studies about ASD 
done in the Western Pacific region (in addition to Japan and China), and she found 
that that prevalence rates ranged from 2.8/10 000 to 94/10 000 (median value of 
11.6/10 000) (Elsabbagh et al., 2012). A subsequent study in China included children 
aged 2–6 years, also stated a prevalence of 11.0 per 10,000 children (Zhang & Ji, 
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2005). Another study from Indonesia reported a prevalence of 11.7 per 10,000 
(Wignyosumarto, Mukhlas, & Shirataki, 1992).  
Samadi et al. found that the Iranian prevalence for five-year old was 6.26 per 10,000 
(Samadi, Mahmoodizadeh, & McConkey, 2012). Dahlia Saab submitted a study about 
National Prevalence and Correlates of Autism in Lebanon and reported that the ASD 
prevalence in Lebanon is 1.48%, with a little predominance of male gender (Saab, 
Chaaya, & Boustany, 2018).  
2.2.3 Gulf Cooperation Council (GCC) region 
The Gulf Cooperation Council (GCC) countries it consists of 6 countries: Saudi 
Arabia, United Arab Emirates (UAE), Kuwait, Sultanate of Oman, Qatar and Bahrain, 
which are located in the Arab peninsula. However, the magnitude of autism in the 
Gulf Cooperation Council (GCC) region is still unclear as epidemiological research 
into this area is considered to be relatively new (Salhia et al., 2014). In Oman, a cross-
sectional study estimated the prevalence of ASD, indicated an overall prevalence of 
1.4 cases per 10,000 children aged 0-14 years (5). In United Arab Emirates the 
weighted prevalence was estimated to be 29 per 10,000, while in the Kingdom of 
Saudi Arabia the ASD prevalence reported was 0.6% (Eapen, Mabrouk, Zoubeidi, & 
Yunis, 2007; Hemdi & Daley, 2017). 
2.2.4 Qatar 
After personal communication with Dr. Alshaban, he told about a study conducted by 
Hamad Bin Khalifa University's Qatar Biomedical Research Institute (QBRI). They 
did screen for primary school in Qatar (93 schools) using lifetime social 
communication questionnaire for children aged 5-12 years to detect the high 
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functioning ASD children. Also, they recruited ASD individuals from all special need 
centers in Qatar and results showed that prevalence of ASD in Qatar 1.4 for both (1 in 
87 children). The result of this prevalence study is in process of publication under 
title: Prevalence and Correlate of Autism Spectrum in Qatar, A National Study 
(Alshaban et al., 2019, in press). 
2.3 Autism risk factors and consanguinity 
Many risk factors have been associated with ASD such as:  multiple birth, congenital 
malformation, delayed initiation of breastfeeding, birth injury or trauma, umbilical-
cord complications, low birth weight, maternal hemorrhage, ABO or Rh 
incompatibility, summer birth, small for gestational age, fetal distress, feeding 
difficulties, neonatal anemia meconium aspiration, hyperbilirubinemia and low 5-
minute Apgar score (Gardener et al., 2011; Salhia et al., 2014; Wassink, Brzustowicz, 
Bartlett, & Szatmari, 2004). Instrumental methods of delivery, postnatal hypoxia, 
jaundice, positive family history and  high paternal and maternal age (>35 years) were 
also related to a noteworthy upsurge in the risk of autism (El-Baz et al., 2011). Other 
factors like lead exposure, mercury and radiation have been proposed as possible 
causes of autism (El-Baz et al., 2016). 
Although neonatal and prenatal exposures were the concentration of several 
epidemiological studies for more than 40 years, Autism etiology is still unknown 
(Gardener et al., 2011). Numerous theories about the pathogenesis suggested the 
interface between various genetic predispositions and environmental factors with 
strong and clear genetic influences (Tchaconas & Adesman, 2013). Studies of twin 
pairs, families, high-risk infant siblings and populations have estimated 
correspondence rates and separation of the disorder within families. The concordance 
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rate was reported as 5-30% in siblings and as 60-70% in monozygous twins; this is in 
agreement with a recurrence rate of 18% in infant siblings and of 33% in multiplex 
families which revealed by a recent large prospective study (Bailey et al., 1995; 
Ozonoff et al., 2011). One of the factors that have been linked to autism and is related 
to genetic is consanguinity. Consanguinity can be defined as the ―relation between 
two people who share a common ancestor‖ (Dahdouh et al., 2016), constructed 
between individuals who are biologically related (Dahdouh et al., 2016). It is 
categorized as 1st, 2nd and 3rd degree. The 1st being the closest kinship. About 8.5% 
of children have consanguineous parents and almost 20% of the world's population 
lives in societies that favor consanguineous unions in Southern coast of the 
Mediterranean, throughout the Middle East and South-East Asia and Northern Africa. 
According to available data among the population of these countries (Dahdouh et al., 
2016).  
The situation in the Middle East region and Qatar is more profound, where 
consanguinity is estimated to be as high as 54% (Bener & Hussain, 2006). Medical 
complications are well recognized in consanguineous marriages; these contain both 
malformations (Jaber et al., 2005) and rare recessive genetic disorders (Bittles, 2008), 
in addition to disorders of complex inheritance, like psychiatric disorders (Mansour et 
al., 2010; Musante & Ropers, 2014; Sharkia et al., 2010).  
Few pieces of literature studied the association between ASD and consanguinity. 
Some studies yielded a significant relation while other did not. In India, a case-control 
study studied the consanguinity as a risk of Autism. The study concluded that 
consanguinity increases the ASD risk (odds ratio= 3.22) (Mamidala et al., 2015). In 
Lebanon, a pilot study was conducted to study the association between autism and 
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multiple risk factors, including consanguinity, older parents age, unhappy maternal 
feeling during pregnancy and previous childhood infection (Hamadé et al., 2013). The 
results came out indicating a significant relationship with the entire factor except 
consanguinity (Hamadé et al., 2013). Even though the overall prevalence of 
consanguineous marriage in Lebanon was high (35.5%) they expanded the 
explanation about the situation by saying that consanguinity was found to increase the 
risk of autism and it needs more research studies with bigger sample size to evaluate 
its significant correlation with autism (Hamadé et al., 2013).  Furthermore, Al-Salehi 
and colleagues discovered that nearly 33% of autistic children in Saudi Arabia were 
an outcome of consanguineous marriage (Salhia et al., 2014) and that autism is related 
to consanguinity as consanguinity was reported by 28.6% of patients from Saudi 
(Salhia et al., 2014). A study examines the consanguinity in ASD children in Qatar 
and reported that 83% of their cohort had one proband, 9.9% with two probands, and 
7.1% with over two, however, the impact of consanguinity as a hazard factor was not 
observed to be significant (Alshaban et al., 2017).  
2.4 Autism Comorbidities 
ASD is associated with high rates of other disorders comorbidity, for example, 
anxiety disorders, fears and phobias, mood disorders, attention deficit hyperactive 
disorder (ADHD) and epilepsy (Ghaziuddin et al., 2002; Leyfer et al., 2006; LoVullo 
& Matson, 2009; Simonoff et al., 2008; Smith & Matson, 2010a, 2010b, 2010c). 
Researchers started to acknowledge and emphasis on comorbidity in individuals with 
ASD recently (LoVullo & Matson, 2009; Smith & Matson, 2010c). Davignon et al, 
2018 studied the frequency of psychiatric and medical comorbidities in a large 
population of ASD individuals. 13% of their cohort were diagnosed with ID (5% 
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sever, 9% moderate, 15% mild, 69% unspecified, 2% profound). ID prevalence 
increased with age (11%, 12% and 19% in age group of 14–17-year-olds, 18–21-year-
olds and 22–25-year-olds respectively) and higher among women (20%) than men 
(11%). 34 % of ASD patients had a co-occurring psychiatric condition. ADHD was 
the most common (15 %) followed by anxiety (14 %), depression (10 %), and bipolar 
disorder (6 %). Most psychiatric conditions were significantly higher in the ASD 
individuals than in each comparison group, and the majority of medical conditions in 
the ASD group were significantly higher than in the ADHD and control groups 
(Davignon, Qian, Massolo, & Croen, 2018). Croen et al 2015 studied 1507 adults with 
ASD to assess the range comorbidity among them. Around one-fifth (19.2%) of adults 
with ASD also had an intellectual disability diagnosis. 54% of them were diagnosed 
with a psychiatric condition: anxiety (29%), depression (26%), bipolar disorder 
(11%), obsessive–compulsive disorder and schizophrenia (8% each). Adults with 
autism had significantly high rates of all main psychiatric disorders including anxiety, 
depression, obsessive–compulsive disorder, schizophrenia, bipolar disorder, and 
suicide attempts. Approximately all medical conditions were significantly higher in 
adults with ASD, such as immune conditions, sleep disorders, seizure and diabetes 
(Croen et al., 2015). Isaac S. Kohane and his colleges evaluated comorbidity 
magnitude of ASD in young adults and children using electronic health records in 
four  hospitals in the Boston area (Kohane et al., 2012). They discovered that among 
ASD patients, 19.44% also had epilepsy, 2.43% had schizophrenia, 0.83% had 
inflammatory bowel, 11.74% had bowel disorders, central nervous system anomalies 
12.45%, type 1 diabetes mellitus 0.79%, muscular dystrophy 0.47% and 1.12% had 
sleep disorders (Kohane et al., 2012).  Another study assessed the frequency of 
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current The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition 
(DSM-IV) comorbidities that comorbid ASD in a special school for adolescents and 
children demonstrating the wide area of intellectual degrees and common ASD 
subgroups (Gjevik et al., 2011). The study concludes that 72% of study populations 
were diagnosed with a minimum of one comorbid disorder.  Forty-one percent had 
anxiety disorders and 31% had ADHD. In older children, obsessive-compulsive 
disorder was more common, while oppositional defiant disorder/conduct disorder 
were more common in pervasive developmental disorder (Gjevik et al., 2011). 
Moreover, E Simonoff, found that 70% of their cohort had one comorbid disorder and 
41% had two or more. The most widely recognized comorbidities were ADHD 
(28.2%), social anxiety disorder (29.2%), and oppositional defiant disorder (28.1%). 
Eighty-four percent of the ADHD patients, received a second comorbid diagnosis 
(Simonoff et al., 2008). 
In the Arab region, research was conducted to study the frequency of comorbid 
psychiatric disorders in a cohort of ASD children enrolled from: Egypt, Saudi Arabia 
and Jordan (Amr et al., 2012). The results found that 63% of the children had at least 
one comorbidity. The most frequently described comorbidities were ADHD (31.6%), 
major depressive disorder (13.3%), anxiety disorders (58.3%) and conduct disorders 
(23.3%) (Amr et al., 2012).  
In Egypt, a study  reported that 90% of cases were associated with one or more 
comorbid conditions and the presence of more than one comorbidity was usually 
associated with male sex and severe type of autism, 72.5% of studied cases suffered 
from comorbid tics (40% occurred in severe autism), 25% presented with associated 
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ADHD, 20% suffered from oppositional defiant disorder (ODD) as comorbid 
conditions, 37.5% had comorbid obsessive compulsive disorder (OCD), and 5% 
suffered from comorbid general anxiety disorder (Elbahaaey, Elkholy, Tobar, & El-
Boraie, 2016).   
2.4.1 Autism, Epilepsy and Intellectual Disability 
  Epilepsy, a frequent ASD comorbidity, is defined as a chronic neurologic 
disorder characterized by repeated spontaneous epileptic seizures (Engel Jr, 2006). 
Epilepsy is occurred mainly in young children or individuals over the age of 65 years; 
but it can happen at any time. Several risk factors are reported to be associated to 
epilepsy such as positive family history of epilepsy, sex, febrile and abnormal 
neonatal history, head trauma and low education (Vozikis, Goulionis, & Nikolakis, 
2012). The co-occurrence of ASD and epilepsy is well recognized (Canitano, 2007; 
Spence & Schneider, 2009; R. Tuchman & Rapin, 2002). Epilepsy prevalence 
estimations in individuals with ASD have varied from 5% to 46% (Spence & 
Schneider, 2009). The variation is due to factors like concurrent intellectual disability 
(ID) (Amiet et al., 2008; Jokiranta et al., 2014; Woolfenden, Sarkozy, Ridley, Coory, 
& Williams, 2012), severe language dysfunction (R. F. Tuchman, Rapin, & Shinnar, 
1991), female gender (Amiet et al., 2008; Danielsson, Gillberg, Billstedt, Gillberg, & 
Olsson, 2005) and age (Hara, 2007; Rossi, Posar, & Parmeggiani, 2000; Volkmar & 
Nelson, 1990), which are all related to the risk of epilepsy in ASD. Amiet et al,
 
in a 
meta-analysis on epilepsy and autism, revealed an association with intellectual 
disability; epilepsy was found in 21.5% of individuals with autism who 
correspondingly had intellectual disability and 8% of individuals without intellectual 
disability (Amiet et al., 2008).  
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The associations between autism and epilepsy continue to be argued. Mannion et al. 
(2013) found that a comorbid diagnosis of epilepsy was reported by 10.1% of ASD 
children and adolescents (Mannion & Leader, 2013). 22% of individuals with ASD 
had epilepsy by the age of 21 years as reported by Bolton et al. (2011) who followed 
up 150 children diagnosed with ASD (Bolton et al., 2011). Pavone et al, 2004 
reported a lower rate of epilepsy, approximately 6% in children with autism without 
additional neurological disorders (Bolton et al., 2011). 
Intellectual Disability (ID) is a disorder characterized by below average intellectual 
functioning (IQ<70) in combination with substantial restrictions in adaptive 
functioning. ID can happen as an isolated condition or accompanied with neurological 
signs, malformations, seizures, impairment of the special senses and behavioral 
disturbances (Simonoff et al., 2008). Several prenatal and perinatal factors have been 
associated with increased risk of ID; advanced maternal age, low maternal education, 
multiparity, maternal alcohol or tobacco use, maternal diabetes or hypertension, 
maternal epilepsy, preterm birth, low birth weight and male sex (Huang, Zhu, Qu, & 
Mu, 2016). In the latest Centers for Disease Control and Prevention (CDC) report, 
31% of children with ASD had intellectual abilities in the ID range (with another 23 
% in the borderline range), although estimations through studies range broadly, from 
26% to 68 % (Ghaziuddin et al., 2002; Leyfer et al., 2006; LoVullo & Matson, 2009). 
The prevalence data demonstrates broadly inconsistent numbers in an overlap 
between ID and ASD. Bryson et al. (2008) reported that 28% of persons with ID also 
showed autism (Bryson, Bradley, Thompson, & Wainwright, 2008). De Bildt et al. 
(2004), using DSM-IV-TR criteria for Pervasive Developmental Disorder, stated a 
16.7% occurrence rate of ID comorbidity (De Bildt et al., 2004). 
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With the emergent global prevalence of ASD, as well as in Qatar (1.4%), research 
should have rapidly advanced efforts to better understand the rise in occurrence and it 
is co morbidities. The weight of autism in GCC region is still unclear as 
epidemiological research into this area is relatively new, so we need to further 
investigate the prevalence, risk factors and characteristics of ASD in the region. 
Consanguinity is most commonly associated with rare recessive conditions, and some 
of the ASD genes are likely to be of this type. The relationship of consanguinity to 
autism spectrum disorder (ASD) risk has not been fully explored, thus it is important 
to study the association of consanguinity with ASD. Also, ASD is a lifelong 
neurodevelopmental disorder with high rates of comorbidities. Nonetheless, it is only 
recently researchers have begun to recognize and focus on comorbidities in 
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Chapter 3: The meta-analysis 
3.1 Methods 
3.1.1 Guidelines 
Meta-Analysis of Observational Studies in Epidemiology guidelines will be applied in 
conducting the meta-analysis. We used the (Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses) PRISMA statement criteria in reporting our systematic 
review (Moher, Liberati, Tetzlaff, & Altman, 2009). 
3.1.2 Protocol and Registration 
We submitted a registration for this review in the International Prospective Register of 
systematic reviews (PROSPERO). The registration number is: 123474. 
3.1.3 Search databases 
An electronic search was conducted in PubMed, EMBASE, and Academic Search 
Complete to gather articles published up to Oct. 2018, with no date restriction. 
3.1.4 Search strategy 
The objective of the literature search is to identify all epidemiological studies that had 
estimated the global prevalence of consanguinity among the ASD individuals and 
compare it that among different populations. The search term was ((autism) or 
(autistic disorder)) and ((consanguinity) or (consanguineous marriage)), the search 
identified 60 studies in PubMed, 117 in Embase and 21 in Academic Search 
Complete. Additional 14 records were added from other sources (Fig 3). The 
systematic search did not identify any systematic review or meta-analysis about 
consanguinity prevalence among ASD individuals. 
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3.1.5 Inclusion criteria 
 English-language studies.  
 Patients with Autism. 
 Consanguinity prevalence measured by any definition. 
3.1.6 Exclusion criteria 
 Overlap of databases. 
 Not addressing ASD patients, separately (not relevant). 
3.1.7 Study Selection 
Title and abstracts of the included studies were reviewed, and duplicates studies were 
removed using Endnote. The Author and Dr. Ibrahem Abdalhakam; a research 
associate at Diabetes, Obesity and Metabolic Research Unit at Qatar Metabolic 
Institute, Hamad Medical Corporation, reviewed independently extracted information 
from articles (Table 2). The agreement between the two reviewers was measured and 
the PRISMA and data extraction table produced by both of them was found similar. 
3.1.8 Data extraction  
We identified 10 publications from 8 different countries (KSA (2 studies), Lebanon (2 
studies), Qatar, Bahrain, Egypt, Jordan, Iran, and Israel). All were peer-reviewed, 
published in English between 2009 and 2018, and reported the prevalence of 
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3.1.9 Data Collection Process 
A standardized data abstraction form was applied to collect the following information 
from eligible studies: first author, year, country, study design, total sample size, 
sample size of ASD cases and consanguinity cases (Table 2). 
3.1.10 Quality of the data 
A risk of bias is the risk of having a systematic error , or having results deviated from 
the truth (Viswanathan et al., 2012), Many tools were established to evaluate the data 
quality (risk of bias) in systematic reviews and meta-analysis , some of them are 
checklist where certain questions are asked and answered yes or no , while others are 
scales where the give a certain score for each component and then the overall score 
calculated to give the final score (Higgins et al.). 
We used a tool established by Hoy et al. (2012) to assess the quality of studies 
involved, since this tool is specifically designed for assessing systematic review of the 
prevalence studies (Hoy et al., 2012). This tool included two main categories which 
are internal and external validity (Figure 1). Internal validity refers to degree of which 
the design and study methodology steps that used have the minimum possible bias. 
While external validity refers to the ability to generalize the results to the larger 
population (Friis, 2010). 
The tool has ten different bias components, the first three items assessed the risk of 
selection bias, item four assess the non-response bias, from five to nine it was all 
about measurement bias, and the last item was about meta-analysis bias (Wang et al., 
2017) (Figure 1). 
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To apply this tool, a score of Y (yes) or N (no) was assigned for each component of 
the tool to compute the quality scores. In computing the scores ―Yes‖ score was 
considered as equivalent to one point, and ―No‖ was equivalent to zero. Then these 
scores are summed was used (range from 0 to 10). The following classification 
created by Hoy et al. (2012) to classify the studies as high, moderate, or low risk of 
bias: Scoring 8 and above indicate having a low risk of bias, a result of 6 or 7 indicate 
moderate risk and having score equal or less than 5 indicate there is a high risk (Wang 




Figure 1. Hoy’s Tool Items of Risk of Bias Assessment 
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3.1.11 Statistical Analysis 
Overall pooled effect size was calculated using appropriate model. Statistical 
heterogeneity was tested by the Cochran Q statistic and reported as I
2
. Random effect 
model was used because there was significant heterogeneity among studies. Funnel 
and Hunter plots were generated to examine publication bias. Comprehensive Meta-
Analysis software, MetaXl version 5.3 and Revman 5.3 were used for all analyses. 
Also, we did subgroup analysis by country and study design. 
3.2 Results 
3.2.1 Qualitative Summary 
10 publications were identified based on our inclusion criteria from 8 different 
countries, 4 of them were from the GCC (KSA (2 studies), Qatar, Bahrain) and the 
rest were from: Lebanon (2 studies), Egypt, Jordan, Iran, and Israel). Figure 2 show 
the geographic location of the included studies.  
Seven of the included articles used a case control study design, and three were used 
cross sectional study design. Studies varied in ASD cases as it ranged between 49 -
500, and the total ASD cases in all studies were 1581 (Table 2). All studies address 
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Table 1  
Included Studies 
Author Year Country Study design 
Farida El-Baz 2011 Egypt case-control 
Fouad Alshaban 2017 Qatar cross-sectional 
Saleh M. Al- Salehi 2009 KSA cross-sectional 
Aline Hamadé 2013 Lebanon case-control 
Muhammad Mahajnah 2015 Israel cross-sectional 
Madhu P. Mamidala 2015 India case-control 
A.M. Al-Ansari 2012 Bahrain case-control 
Dikran Richard Guisso 2018 Lebanon case-control 
Roksana Sasanfar 2010 Iran case-control 
Adnan Amin Alsulaimani 2014 KSA case-control 
 
 
Each of the 10 included studies are narratively summarized below as part of the 
systematic review. 
Farida El-Baz et al. (2011) conducted a study in Egypt that included 100 autistic 
patients. At 1.5 years of age, 46% of them had autistic symptoms and at 2 years of age 
32%. Fifty-five percent experienced moderate to severe intellectual disability (IQ= 
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20–70), 36% lower than normal intellectual function (IQ= 71–89), 13% were outcome 
of consanguineous marriage and 9% average intellectual function (IQ= 90–109). 
Advanced mother age (>35 years) at birth was reported by 23% of autistic children 
paralleled to only 9.5% of controls (P value 0.001).  Paternal age at delivery time          
(> 35years) was higher in the cases group than in the controls group (91% and 83.5% 
respectively) which was statistically significant (P value < 0.001). A statistically 
significant association of positive family history with the risk of autism was found (16 
% of their sample). All developmental milestones studied were delayed among 
autistic children compared to control group (P value < 0.001). Birth factors (low birth 
weight history and outcome of caesarian section) and postnatal factors (hypoxia, 
resuscitation, and jaundice) were statistically significant as risk factors for autism. 
In Saudi Arabia, Saleh M. Al - Salehi & Elham H. Al-Hifthy et al. (2009) studied 49 
ASD children in Saudi Arabia for reasons of referral and clinical characteristics. Their 
average age was 6.3 years, females were older, and 14 children were outcome of 
consanguineous marriage. Five patients had no speech and 5 had a history of language 
deterioration around the age of 18–24 months. Before the age of three, 42 patients had 
experienced symptoms. Chromosomal abnormality was found in one patient. Other 
comorbidity of seizure disorder was reported by 11 patients, mental retardation by 27 
patients and hyperactivity and impulsiveness by 22 patients. Glucose 6 Phosphate 
Deficiency (G6PD) was found in 2 patients and cerebral paralysis and Tourette in 
patient each. Twenty - five patients took psychotropic medicines and 14 patients came 
from consanguineous marriages, which considered high percentage (29%), but it does 
not have a good reflection as their sample size was small. 
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Aline Hamadé et al. (2012) conducted a study on autism correlates in the Lebanese 
population in Lebanon. Their sample size was 86 autism cases from specialized 
schools and control group involve 172 school kids. They reported a significant 
association between autism and male gender, advanced parents age, unhappy maternal 
emotion throughout gestation, living around industrial area and history of infection 
during childhood (OR= 3.38, 1.27, 5.77, 6.58 and 8.85 respectively). Consanguinity 
was reported by 11 patients (13%). Maternal and paternal age were not associated 
significantly (28.84 and 29.38 for cases and 34.84 and 35.43 for controls, 
respectively). 
Muhammad Mahajnah et al. (2015) collected demographic and clinical characteristics 
of two hundred ASD children from Arab and Jewish sectors in Israel that were 
evaluated in two child development centers. After that, they compared these tow 
ethnics group in terms of incidence and medical co - morbidity of autism. These 
children's psychiatric comorbidity and medical profile was similar to the studies 
published around the world. The Israel's Jewish sector autism prevalence was like that 
of the Arab sector in this study. Consanguinity (9%), incidence of mental retardation, 
autistic family members and severe autistic manifestations observed more in Arab 
patients (P < 0.05), while milder forms (such as Asperger syndrome and PDD-NOS) 
were more common in the Jewish sector. Genetic and cultural factors could explain 
this discrepancy. 
In India, Madhu P. Mamidala has been studying India's consanguinity and association 
with autism spectrum disorder. They included 500 ASD kids and 500 controls 
between the ages of 2 and 10. The male - to - female ratio was calculated as 4:1. 
Consanguinity level was significant among ASD cases compared to controls (P < 
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0.0001). Univariate analysis showed that consanguineous marriage is an ASD risk 
factor (OR= 3.22, 95% CI—2.07, 4.62, P < 0.0001). LBW was considered as a 
significant risk factor for ASD (OR= 2.02), when they include consanguinity in the 
multivariate analysis.  
A.M. Al - Ansari et al (2012) conducted a study to identify the prevalence of autistic 
disorder in Bahrain and to assess some of the characteristics of the population and 
family. A case-control design was used to select 100 children who were diagnosed 
with DSM-IV TR autistic disorder during the period 2000–2010. An equal number of 
controls were selected, matched for sex and age group that had been diagnosed with 
nocturnal enuresis and no psychopathology. The prevalence of autistic disorder was 
more in males with a male: female sex ratio of 4:1 and reported at 4.3 per 10,000 
populations. Consanguinity was reported by 29 cases. Caesarean section delivery was 
significantly more in cases than controls and had mothers suffering prenatal 
complications. Bahrain's prevalence estimate is comparable with previous reports 
using similar methods. Autistic disorder may be associated with obstetric 
complications and delivery of the caesarean section. 
Dikran Richard Guisso et al (2018) conduct a study on the association of pregnancy 
and natal complications with other ASD factors in children from Lebanon between 2 
and 18 years old. One-hundred and thirty-six children with ASD from the Special 
Kids Clinic as well as 178 controls recruited from Beirut were interviewed. 
Consanguinity was reported by 14% of the cases. Difficulties in feeding postpartum, 
male gender, maternal infections / complications during pregnancy, consanguinity, 
psychiatric disorder family history were risk factors for ASD. ASD was negatively 
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associated with being born first / second and maternal psychological support during 
pregnancy. 
Roksana Sasanfar et al (2010), recruited 179 children with autism and 1611 matched 
control children from Iran to investigate the association between autism and parents 
age. Nine controls groups on sex, parental education, consanguineous marriage, birth 
order, province of residence and urbanism were matched in each case. The model of 
Cox regression was used to perform on matched data conditional logistical regression. 
They found a significant relationship between advanced father age, but not mother 
age, and bigger risk of autism. Higher - educated parents had high risk of having 
autistic children with a parental age dose - response effect based on overall effect of 
parental age and education analysis. Consanguinity was reported by 58 cases. 
Dr. Adnan Amin Alsulaimani et al (2012) conducted a study to interpret the 
psychometric, clinical and epidemiological aspects of a cohort of children with autism 
from KSA to conclude potential risk factors for autism. They enrolled 60 ASD cases 
diagnosed based DSM - IV - TR criteria. During June 2011 to May 2013, cases were 
recruited from the mental health clinic integrated into the Pediatric Clinic, Prince 
Mansour Military Hospital. The control group consisted of one hundred and twenty 
healthy children. They have been recruited from various ambulatory clinics. For each 
case, 2 control subjects were recruited and matched in habitat, gender, age and 
environment. no statistically significant variance between controls and cases with 
respect to their weight, age, height, mother's age at delivery time and birth order, 
whereas father's age at delivery time was lower in controls compared to cases, which 
was statistically significant. Fifty - five percent of autistic child parents were 
consanguineous at first degree compared to just 36.7% of controls (p value= 0.019). 
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In addition, 39% of autistic children had positive family history of psychiatric disease 
compared to just 18.3 percent of controls (p value= 0.03). 36.9 percent compared to 
only 11.7% of families of autistic patient cases and controls, respectively, had a 
positive family history of autism (p value= 0.0001). 
Fouad Alshaban et al (2017) conceived a study in Qatar to define ASD clinical 
characteristics and its correlates. ASD patients (171 patients) have been recruited 
from the Shafallah Center for Children with Special Needs. The analysis involved the 
subsequent factors: sex, nationality, consanguinity, socioeconomic status, age, 
comorbidity and prenatal and postnatal complications. Out of the 171 patients, 80% 
were males (male to female ratio of 4:1). Consanguinity was reported by 69 cases. 
Also, 83% of families with one proband, 9.9% had 2 probands, and 7.1% with more 
than two. Intellectual disability was found in 83%, epilepsy in 18.8% and 76.6% of 
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Figure 3. PRISMA Flowchart Diagram
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Table 2  
 Characteristics of the included studies 
Author Farida El-Baz et al Fouad Alshaban et al SALEH M.AL-SALEHI et al 
Random sampling No No No 
Population  Clinical specialized schools Clinical 
Total sample size 300 171 49 
Sample size, ASD/consanguineous 100/13 171/69 49/14 
Sample size, Control/consanguineous 200/43 NA NA 
Consanguinity measurement/degrees self-reported/Not reported self-reported/Not reported self-reported/Not reported 
ASD Age ratio 2 to 13 years not specified mean age 6.3 years 
ASD Gender ratio 
males (82%) and females 
(18%) 
80% males and 20% females 37 males and 12 females 
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Table 2  
Characteristics of the included studies (Continued) 
Author A.M. Al-Ansari et al Dikran Richard Guisso et al 
Random sampling Yes Yes 
Total sample size 200 314 
Population  Clinical Clinical 
Sample size of ASD/consanguineous 100/29 136/19 
Sample size of Control/consanguineous 100/NA 178/13 
Consanguinity measurement/Degrees self-reported/reported self-reported/Not reported 
ASD Age ratio 2–27 years 2–18 years 
ASD Gender ratio male to female ratio 4:1 males (64%) 
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Table 2   
Characteristics of the included studies (Continued) 
Author Roksana Sasanfar et al Adnan Amin Alsulaimani et al 
Random sampling No No 




Sample size of ASD/consanguineous 179/58 60/33 
Sample size of 
Control/consanguineous 
549354/167001 120/44 
Consanguinity measurement/Degrees self-reported/Not reported self-reported/reported 
ASD Age ratio 5- 11 years 19m to 96m 
ASD Gender ratio male to female ratio was 4:1 males (76.7%) and females (23.3%) 
Diagnosis tool child psychiatrist's DSM-IV-TR criteria 
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3.2.2 Risk of Bias 
           Of the 10 studies involved in our study, 2 (20%) articles met all the ten quality 
criteria ( Dikran,Fadi,Dahila et al 2018, Madhu P. Mamidala et al 2015), 7 (70%) 
studies have low risk of bias (Saleh M. Al-Salehi et al 2009, Aline Hamadé et al 2013, 
Muhammad Mahajnah et al 2015, Roksana Sasanfar et al 2010, Adnan Amin 
Alsulaimani et al 2014  , A.M. Al-Ansari et al 2012 and Farida El-Baz et al 2011) and 
one study has moderate risk of bias (Fouad Alshaban et al 2017).   
            In regards to the external validity five of the studies get a full score (4/4) 
(Aline Hamadé et al 2013, Muhammad Mahajnah et al 2015, Madhu P. Mamidala et 
al 2015, A.M. Al-Ansari et al 2012 and Dikran Richard Guisso et al 2018) while the 
other five can be considered to have a good external validity (Farida El-Baz et al 
2011, Fouad Alshaban et al 2017, Saleh M. Al-Salehi et al 2009, Roksana Sasanfar et 
al 2010 and Adnan Amin Alsulaimani et al 2014 ). Based on question 3 of the 
external validity; was some form of random selection used to select the sample or was 
a census undertaken? 50% of studies rated poorly for having a random assignment of 
the sample population (Farida El-Baz et al 2011, Fouad Alshaban et al 2017, Saleh M. 
Al-Salehi et al 2009, Roksana Sasanfar et al 2010 and Adnan Amin Alsulaimani et al 
2014). All the studies have representative sample of the whole national population 
and the target population. 
            Regarding the internal validity, 30% of the studies had errors in the numerator 
and denominator for the parameter of interest (Fouad Alshaban et al 2017, Saleh M. 
Al-Salehi et al 2009 and Aline Hamadé et al 2013). Moreover, all of them had an 
acceptable definition of the cases and used similar method in data collection from all 
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patients which lead to increased validity and reliability. Figure 3 and 4 shows a plot 
and summary of risk of bias results. 
  Having studies with no, low and moderate risk of bias is due to establishing 
highly selective inclusion criteria to include studies in meta-analysis, as well as most 
of the studies had similar characteristics and measurements. Since we are 
investigating specific exposure in a specific population, all studiers considered were 
answered Y (Yes). Regarding the sampling frame question, all of studies were 
representative of the target population, so all of them got Y(Yes) for this question. 
When evaluating the non-response of participants (question 4), none of the studies 
had non-response problem, so there was low risk of non-response bias. Forty percent 
of the studies used medical records to collect the data, while the rest collect data 
directly from the participants (Question 5). All studies showed validity and reliability 
as they used standardized tool for ASD diagnosis (Question 7). Regarding question on 
whether the prevalence changes with time (question 9), all the studies got Y (Yes) as 
ASD prevalence changes through time.
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Table 3  
Tool for Assessing Risk of Bias 
First Author (Year) 
External validity Internal validity 
Quality Score Risk of Bias 
1 2 3 4 5 6 7 8 9 10 
 Dikran et al,2018 Y Y Y Y Y Y Y Y Y Y 10 NO 
Hamadé et al,2013 Y Y Y Y Y Y Y Y Y N 9 LOW 
Fouad et al,2017(Qatar) Y Y N Y N Y Y Y Y N 7 MODERATE 
Saleh.M.Al-Salehi et al,2009 Y Y N Y Y Y Y Y Y N 8 LOW 
Muhammed Mahajnah et al,2014 Y Y Y Y N Y Y Y Y Y 9 LOW 
Madhu P. Mamidala et al, 2015  Y Y Y Y Y Y Y Y Y Y 10 NO 
A.M.AL-Ansari et al,2012 Y Y Y Y N Y Y Y Y Y 9 LOW 
Roksana Sasanfar et al,2012 Y Y N Y N Y Y Y Y Y 8 LOW 
Farida et al,2011 Y Y N Y Y Y Y Y Y Y 9 LOW 
Dr.Adnan et al,2014 Y Y N Y Y Y Y Y Y Y 9 LOW 
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Figure 4. Risk of Bias graph 
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3.2.3 Heterogeneity Assessments  
There are variations in the objectives and aims between the included studies in this 
meta-analysis. From the total included studies, we calculated pooled prevalence of 
consanguinity among ASD patients. There was significant heterogeneity among these 
studies (Q value= 113.3, P value<0.001, I
2 
= 92%). As there is high heterogeneity, the 
random effect model was used to estimate the pooled prevalence. 
The pooled prevalence for cross-sectional studies was 23% (95% CI:4%-50%), there 
was a high heterogeneity across studies (Q value=54.8, P value=0.001, I
2 
= 96%). For 
case-control studies the estimated pooled prevalence was 23.3% (95% CI: 15.8%-
33%), there was significant heterogeneity (Q value= 58.9, P value<0.001, I
2 
= 89%). 
In GCC countries, the estimated pooled prevalence of consanguinity among ASD 
patients was 38% (95% CI: 28%-49%), and there was considerable heterogeneity 
detected between these studies (Q value=12.7, P value = 0.01, I
2 
= 76%). While for 
the pooled prevalence for the other than GCC countries was 16.2% (95% CI: 10.8%-




3.2.4 Quantitative Synthesis (Random effect mode) 
The overall pooled prevalence of consanguinity among ASD patients based on REM 
was 24% (95% CI: 17%-32%) (Figure 6). The prevalence reported by Adnan et al, 
2014 was higher than this study’s overall pooled prevalence, 55% (95% CI: 42.4%-
67%). The estimated prevalence in Fouad et al, 2017, Roksana Sasanfar et al, 2012, 
A.M.AL-Ansari et al, 2012 and Saleh.M.Al-Salehi et al, 2009 were relatively higher 
than our overall pooled prevalence, 40%(95%CI:33%-48%),32.4% (95% CI: 26%-
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39.6%), 29% (95% CI: 21%-38.6%) and 28.6% (95% CI: 17.7%-42.6%) respectively. 
In Madhu P. Mamidala et al, 2015, the prevalence was slightly less than  the pooled 
prevalence, 20% (95% CI: 16.7%-23.7%), while it were 14% (95% CI: 9.1%-20.9%), 
13% (95% CI: 7.7%-21.1%) and 12.8% (95% CI: 7.2%-21.6%) in Dikran et al, 2018, 
Farida et al, 2011 and Hamadé et al, 2013 respectively. The lowest prevalence was 
reported in Muhammed Mahajnah et al, 2014, 9% (95% CI: 5.8%-14.7%).  
From the cross-sectional studies (Fouad et al, 2017, Saleh.M. Al-Salehi et al, 2009 
and Muhammed Mahajnah et al, 2014), the pooled prevalence of consanguinity 
among ASD patients was 23% (95% CI: 4%-50%) (Figure 7). The highest prevalence 
was reported in Fouad et al, 2017,40%(95%CI:33%-48%), followed by Saleh.M. Al-
Salehi et al, 2009, 28% (95% CI: 17.7%-42.6%), while Muhammed Mahajnah et al, 
2014 reported the lowest prevalence, 9% (95% CI: 5.8%-14.7%). 
Regarding case-control studies (Dikran et al, 2018, Farida et al,v2011 and Hamadé et 
al, 2013, Dr. Adnan et al, 2014, Roksana Sasanfar et al, 2012, A.M.AL-Ansari et al, 
2012 and Madhu P. Mamidala et al, 2015) the estimated pooled prevalence was 
23.3% (95% CI: 15.8%-33%) (Figure 8). The highest prevalence was reported by Dr. 
Adnan et al, 2014 was higher than the overall pooled prevalence, 55% (95% CI: 
42.4%-67%). Followed by Roksana Sasanfar et al, 2012 and A.M.AL-Ansari et al, 
2012, 32.4% (95% CI: 26%-39.6%) and 29% (95% CI: 21%-38.6%) respectively. The 
other 3 studies (Dikran et al,2018, Farida et al,2011 and Hamadé et al,2013) have an 
estimated prevalence lower than our pooled prevalence (14% (95% CI: 9.1%-20.9%), 
13% (95% CI: 7.7%-21.1%) and 12.8% (95% CI: 7.2%-21.6%) respectively). 
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As in figure 9, the estimated pooled prevalence of consanguinity among ASD patients 
in GCC countries (Qatar, Bahrain and KSA) reported from 4 studies (Fouad et al, 
2017, Saleh.M. Al-Salehi et al, 2009, Dr. Adnan et al, 2014 and A.M.AL-Ansari et al, 
2012) was38% (95% CI: 28%-49%). Adnan et al, 2014 reported higher prevalence 
than the overall pooled prevalence, 55% (95% CI: 42.4%-67%), followed by Fouad et 
al, 2017, 40% (95% CI: 33%-48%). A.M.AL-Ansari et al, 2012 and Saleh.M. Al-
Salehi et al, 2009 reported approximately the same prevalence, 29% (95% CI: 21%-
38.6%) and 28.6% (95% CI: 17.7%-42.6%) respectively. 
Regarding the other countries (other than GCC countries) the estimated pooled 
prevalence reported in six studies (Roksana Sasanfar et al, 2012, Madhu P. Mamidala 
et al, 2015, Dikran et al, 2018, Farida et al, 2011 and Hamadé et al, 2013 and 
Muhammed Mahajnah et al, 2014), was 16.2% (95% CI: 10.8%-23.5%). The highest 
prevalence was reported in Roksana Sasanfar et al, 2012, 32.4% (95% CI: 26%-
39.6%), while Muhammed Mahajnah et al, 2014 reported the lowest prevalence, 9% 
(95% CI: 5.8%-14.7%) as it shown in figure 10. 
Figure 11. Show the pooled estimated odd ratio for consanguinity among ASD 
patients and controls in the case-control studies. We excluded A.M.AL-Ansari et al, 
2012 from this analysis as it did not mention the prevalence of consanguinity among 
controls; the other 6 case-control studies were included. The pooled estimated odd 
ratio was 1.5 (95% CI: 0.896-2.561).  Madhu P. Mamidala et al, 2015 showed the 
highest odd ratio,3.2 (95% CI: 2.15-4.83), while Farida et al, 2011 showed the least, 
0.54 (95% CI: 0.28-1.07). In addition to Muhammed Mahajnah et al, 2014, Dikran et 
al, 2018 and Dr. Adnan et al, 2014 also reported higher than pooled estimated odd 
ratio, 2.66 (95% CI: 0.98-4.34) and 2.11 (95% CI: 1.2-3.96) respectively. Roksana 
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Sasanfar et al, 2012 and Hamadé et al, 2013 reported odd ratio was 1.34 (95% CI: 
0.59-2.99) and 1.09 (95% CI: 0.80-1.55) respectively. 
 
 















Figure 7. The pooled prevalence of consanguinity among ASD patients in cross-



































Figure 10. The pooled prevalence of consanguinity among ASD patients in the other 
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Farida El-Baz et al, 2011 
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Aline Hamadé et al, 2013 
MuhammadMahajnah et al, 2015 
Madhu P. Mamidala et al, 2015 
A.M. Al-Ansari et al, 2012 
Dikran Richard Guisso et al, 2018 
Roksana Sasanfar et al, 2010 
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3.2.5 Subgroub Analysis 
We carried out a subgroub analysis based on study design (cross-sectional and case-
control) and geographical location (GCC and Other countries) of the studies.  
 
 
Table 5   
Subgroup analysis of prevalence of consanguinity among ASD patients: study design 
Study design No of studies 
(Patients) 
Pooled prevalence of consanguinity 







23% (95% CI: 4%-50%) 





The estimates were different, but the confidence interval was overlapping, this 
indicates that there was no statistically significant difference according to the study 
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Table 6  
Subgroup analysis of prevalence of consanguinity among ASD patients: study country 
Study country No of studies 
(Patients) 
Pooled prevalence of 







38% (95% CI: 28%-49%) 





On the other hand, regarding consanguinity prevalence among ASD patients the 
estimate is higher among the GCC countries compared to other countries. 
3.2.6 Publication Bias 
     Publication bias was detected by the funnel plot by plotting the logit of the 
consanguinity prevalence against the standard error (study size) among ASD patients, 
studies were scattered around the pooled estimate and the plot was symmetric with no 
gaps which indicate no evidence of publication bias. Nevertheless, conventional 
funnel plots that assess publication bias are imprecise for prevalence meta-analysis as 
proposed by Hunter et al. (2014). Therefore, provided an alternative which are funnel 
plot of study size against log odds which could be more accurate in studying 
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Chapter 4: Cross-sectional study 
4.1 Methods  
This is a cross-sectional study using secondary data from the Autism spectrum 
disorder in Qatar: Profiles and correlates of a large clinical sample short report data. 
4.1.1 Study Population and data sources 
Participation in the current study was based on participation in a previous research 
study  titled ―Autism spectrum disorder in Qatar: Profiles and correlates of a large 
clinical sample‖ (Alshaban et al., 2017). Recruiting of the participants took place 
between the years 2011 and 2015 at Shafallah Center for Individuals with Special 
Needs. The center was established in 1999 to provide services for both citizens and 
expatriates with disabilities, mainly ASD, between the ages of 3 and 18 years of age.  
4.1.3 Data collection: 
Data collection took place between the years 2011 and 2015 at Shafallah Center for 
Individuals with Special Needs through a comprehensive record review which 
contained diagnostic, medical, and developmental history. This enabled access to 
information regarding comorbid conditions, intellectual ability, family history of ASD 
and consanguinity, prenatal and postnatal history, and other relevant information. 
4.1.4 Sample Size: 
A total of 171 cases of ASD were identified from Shafallah Center for Individuals 
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4.1.5 Study variables 
To achieve our aim in this study; the association of consanguinity with ASD 
comorbidities (epilepsy and ID) we included the variables mentioned below: 
4.1.5.1 Outcome variables 
 Intellectual Disability: mild, moderate and severe. 
 Epilepsy: Yes, no. 
4.1.5.2 Main exposure variable  
 Consanguinity: Yes, no. 
4.1.5.3 Other potential variables 
 Socio-Demographic factors: age and gender, nationality number of 
proband and monthly income. 
 Environmental and genetic risk factors: Method of labor, feeding 
practices and prenatal and postnatal factors (hypoxia, jaundice and 
head trauma). 
 Syndromic ASD: Fragile X, Rett’s syndrome and Tuberous sclerosis.  
4.1.6 Data management and analysis plan: 
Anonymous secondary data was properly cleaned and checked for range and 
consistency. Univariable, and multivariable analyses were conducted to estimate the 
prevalence of consanguinity and assess associations between consanguinity and both 
epilepsy and ID among ASD children. The multivariable analysis included 
consanguinity and both epilepsy and ID control of other potential confounding 
determinants.  Descriptive analysis summarized all potential determinant and 
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consanguinity using proportions. Univariable and multivariable logistic regression 
models were used to model the likelihood of consanguinity association with both 
epilepsy and ID. Goodness of fit was done using H and L goodness of fit test, and the 
model was found to be fit (P-value >0.05). 
Associations were quantified using unadjusted and adjusted Odds Ratios and their 
95% confidence intervals. Purposive selection method was used to develop the best 
parsimonious multivariable logistic regression models. Also, clinically significant 
variables were included in both multivariable models. 
4.1.8 Ethical considerations 
De-identified and anonymous data used in this project were previously collected 
electronically and were stored in password protected in an accredited USB flash.  
Data were primarily extracted by Dr. F. Alshaban from Shafallah center records. As 
for the procedure, it included acquisition of consent forms signed by patients 
voluntarily. Patients were given the complete right to withdraw at any moment 
without exception. Hence data were confidential, and privacy was maintained 
throughout the research process. Ethical approval was obtained from both Institutional 
Review Board of Hamad Medical Corporation and Qatar University.  
4.2 Results  
Participation in the current study was based on participation in a previous research 
study titled ―Autism spectrum disorder in Qatar: Profiles and correlates of a large 
clinical sample‖ (Alshaban et al., 2017). Recruiting of the participants took place 
between the years 2011 and 2015 at Shafallah Center for Individuals with Special 
Needs. 
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4.2.1 Descriptive analysis 
This study included a total of 171 cases. The mean age of the study population was 
13.5 years (SD=5.9years) (Table 7). About 47% of the study population were Qatari 
nationals and majority were males (80%) translating into a male-to-female ratio 4:1. 
The largest age group was between 10 and 14 years of age (53%) while the smallest 
was between 0 and 4 years (2.3%). Seventy percent of the cases were outcome of 
normal vaginal delivery, 22% were delivered by caesarian section and 8% were 
delivered by assisted vaginal delivery. Hypoxia was reported in 13% of the cases and 
jaundice and head trauma were reported in 11% and 5% of the cases respectively. 
Results showed that 47.5% of families were in the highest income group (>20,000 QR 
per month), whereas 40.9% had a monthly income between 10,000–20,000 QR, and 
only 21.5% had a monthly income less than 10,000 QR. Consanguinity was reported 
by 40% of the cases families. However, ASD affected one sibling in 83% of the cases 
families, two siblings in only 9.9% of cases families and only 7.1% of families had 
more than two siblings affected. In terms of language,76.6% of the cases were 
nonverbal or delayed. Eighty three percent of the cases were in ID range with 
approximately half of the patients having moderate ID (48.5%) based on Stanford-
Binet test (Gale, 2003). Epilepsy was found in 19% within this sample, while 8 cases 
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Table 7  
Distribution of sociodemographic variables of the study population 
Variables Frequency Percentage 
Age Category 
  
      0 – 4 4 2.3 
      5 – 9 44 25.7 
      10 – 14 53 30.9 
      15 – 19 49 28.6 
      >20 21 12.2 
Gender 
  
     Male 136 79.5 




     Qatari 80 47.0 
     Non-Qatari 91 53.0 
Consanguinity 
       Consanguineous 69 40.3 
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Variables Frequency Percentage 
Number of proband 
 
      Single family(1proband) 142 83.0 
     Extended family (2 probands) 17 9.9 
     Extended family (>2 probands) 12 7.1 
Monthly family income (QR) 
       <10,000 37 21.5 
     10–20,000 70 40.9 
     <20,000 64 47.5 
Method of labor  
 
     Normal unassisted delivery 120 70.0 
     C-section 38 22.0 
     Forceps/or suction 10 6.0 
     Protracted/induced 3 2.0 
Prenatal and postnatal factors 
  
  Hypoxia 
  
     Yes 23 13.5 
      No 148 86.5 
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Variables Frequency Percentage 
   Jaundice 
  
     Yes 19 11.0 
     No 152 89.0 
  Head trauma 
  
     Yes 8 4.7 
     No 163 95.3 
Syndromic ASD and other comorbidities   
  Fragile X   
     Full mutation 3 1.8 
     Pre-mutation 2 1.2 
  Rett’s syndrome   
     MECP2 +ve 3 1.8 
Tuberous sclerosis 1 0.5 
  None 162 94.7 
Epilepsy 
  
     Yes 32 18.7 
     No 139 81.3 
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Variables Frequency Percentage 
Intellectual Disability (ID)   
     Normal 29 17.0 
     Mild 37 21.6 
     Moderate 83 48.5 
     Sever 22 12.9 
Communication (Language) 
       Verbal 40 23.4 
     Nonverbal 82 48.0 
     Delayed 49 28.6 
 
 
4.2.2 Descriptive analysis: Epilepsy 
Table 8. presents the distribution of the potential risk factors among ASD cases with 
and without epilepsy. Thirty-two cases had a comorbid diagnosis of epilepsy; 18.7% 
of the total sample. 24 cases were in male (17.7%), 13 cases in Qatari (16.3%) and 27 
cases in families with a single proband (19%). Regarding consanguinity, 16 out of the 
32 epileptic patients were product of consanguineous marriage (23.2%). Moreover, 
around 21 cases were outcome of normal vaginal delivery (17.5%), 12 were nonverbal 
(14.6%). Most of the epileptic patients do not have history of prenatal and post-natal 
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risk factors (hypoxia, jaundice, head trauma: 26 cases (17.6%), 27 cases (17.8%) and 
30 cases (18.4%) respectively). 
 
Table 8  
Characteristics of ASD patients with and without Epilepsy (N=171) 
Characteristics With Epilepsy (N=32) Without Epilepsy (N=139) 
Age categories 
  
     0 - 4 1 (25.0) 3 (75.0) 
     5 - 9 5 (11.4) 39 (88.6) 
     10 - 14 10 (18.9) 43 (81.1) 
     15 - 19 10 (20.4) 39 (79.6) 
     >20 6 (28.6) 15 (71.4) 
Gender 
  
     Female 8 (22.9) 27 (77.1) 
     Male 24 (17.7) 112 (82.3) 
Nationality 
  
     Qatari 13 (16.3) 67 (83.7) 
     Non-Qatari 19 (20.9) 72 (79.1) 
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Characteristics With Epilepsy (N=32) Without Epilepsy (N=139) 
Consanguinity 
  
     Yes 16 (23.2) 53 (76.8) 
     No 16 (15.7) 86 (84.3) 
No. of proband 
  
     Single 27 (19.0) 115 (81.0) 
     Extended (2 proband) 4 (23.5) 13 (76.5) 
     Extended (>2 proband) 1 (8.3) 11 (91.7) 
Monthly family income (QR) 
  
     <10,000 6 (16.2) 31 (83.8) 
     10–20,000 15 (21.4) 55 (78.6) 
     >20,000 11 (17.2) 53 (82.8) 
Mode of delivery 
  
     NVD 21 (17.5) 99 (82.5) 
     C-Section 9 (23.7) 29 (76.3) 
     Forceps/Suction 2 (20.0) 8 (80.0) 
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Characteristics With Epilepsy (N=32) Without Epilepsy (N=139) 
Prenatal and postnatal factors   
  Hypoxia 
  
     Yes 6 (26.0) 17 (74.0) 
     No 26 (17.6) 122 (82.4) 
Head trauma 
  
     Yes 2 (25.0) 6 (75.0) 
     No 30(18.4) 133 (81.6) 
  Neonatal jaundice 
  
     Yes 5 (26.3) 14 (73.7) 
     No 27 (17.8) 125 (82.2) 
  Language 
  
     Verbal 10 (25.0) 30 (75.0) 
     Delayed 10 (20.4) 39 (79.6) 
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4.2.3 Univariable analysis: Epilepsy 
Univariable logistic regression analysis was done to select potential candidate 
variables for the multivariable logistic regression analysis. Based on the pre-set p-
value criteria cut off point ≤0.25, age, gender, nationality, number of the family 
probands, monthly income, mode of delivery, feeding practice, language and the 
postnatal and prenatal factors not significant and therefore were not included in the 
adjusted model. 
The univariable logistic regression showed that only consanguinity was significantly 
associated with epilepsy (P-value=0.220) (Table 9). Although not significant in the 
univariable model, age, gender, prenatal and postnatal factors (hypoxia and neonatal 
jaundice) were included in the adjusted model based on clinical significance. Despite 
that history of head trauma is considered an important risk factor for epilepsy, this 
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Table 9   
Crude Association between Epilepsy and potential risk factors (Univariable logistic 
regression analysis) 
Variable OR 95% CI  P value 
Age categories 
     0 - 4 
     5 - 9 
     10 - 14 
     15 – 19 








0.071 – 9.68 
0.08 – 1.20 
0.18 – 1.87 







     Male 














     Qatari 





0.34 – 1.60 
  
0.44 
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Variable Variable Variable Variable Variable 
Consanguinity 
     Yes 









No. of family proband 
     Single 
     Extended (2 proband) 






0.32 – 20.87 








Monthly income (QR) 
       10.000 – 20.000 
     >20.000 






0.49 – 4.00 





Mode of delivery 
     C-Section 
     Forceps/Suction 
     Protracted/Induced 







0.60 – 3.54 
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Variable Variable Variable Variable Variable 
Language 
     Delayed 
     Non-verbal 






0.28 – 2.08 






     Yes 











     Yes 











     Yes 
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4.2.4 Multivariable analysis: Epilepsy 
In the final adjusted multivariable logistics regression model, none of the variables 
were statistically significant associated with epilepsy (Table 10). The odds of having 
epilepsy increased by 90% among those whose parents were consanguineous 
(OR = 1.90; 95% CI: 0.83 –4.23). History of hypoxia was associated with 50% higher 
odds of having epilepsy (OR = 1.50; 95% CI: 0.54 –4.40). Also, history of neonatal 
jaundice was associated with 70% higher odds of having epilepsy (OR = 1.70; 95% 
CI: 0.54 –5.54). However male gender showed to decrease the odds having epilepsy 
by 30% (OR 0.70; 95% CI: 0.25-1.73). Cases aged 5-9 years old have the lowest odds 
of having epilepsy (OR= 0.20; 95% CI: 0.06-0.98) compared to the others age 
categories, which was statistically significant. All other variables were not statistically 
significant, so will report the univariable analysis. 
For confounding assessment, we entered variables that were not included in the full 
model separately (nationality, number of family proband, monthly income, mode of 
delivery and language). the coefficients of these variables did not change by 15-20%, 
indicating that these variables did not confound the relationship between 
consanguinity and epilepsy. Hosmer and Lemeshow showed that model fit well (P 
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Table 10  
Adjusted association between Epilepsy and potential risk factors (Multivariate logistic 
regression analysis) 
Variable OR 95% CI  P value 
Age categories 
     0 - 4 
     5 - 9 
     10 - 14 
     15 – 19 








0.05 – 7.89 
0.06 – 0.98 








     Male 














     Yes 
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Variable OR 95% CI  P value 
Neonatal jaundice 
     Yes 











     Yes 












4.2.5 Descriptive analysis: Intellectual Disability 
Table 11. presents the distribution of potential risk factors among autistic patients 
who had ID. These cases constitute 83% of our sample (n=142). 110 cases with ID 
were male (80.9%), 65 cases were Qatari (81.3%). 3 cases aged (0-4) (75%), 34 cases 
aged (5-9) (77.3%), 49 cases aged (10-14) (92.5%), 40 cases aged (15-19) (81.6%) 
and 16 cases aged > 20 years (76.2%). 117 cases were from families with single 
family proband (82.4%). In regard to consanguinity, 60 cases had consanguineous 
parents (87%). Furthermore, 98 of the cases were vaginally delivered (81.7%), 72 
cases were nonverbal (87.8%). Most of the ID patients do not have history of prenatal 
and post-natal risk factors (hypoxia, jaundice, head trauma: 121 cases (81.8%), 125 
cases (82.2%) and 135 cases (82.8%) respectively). Hosmer and Lemeshow showed 
that model fit well (P value > 0.05). 
  
   
64 
 
Table 11  
Characteristics of ASD patients with and without Intellectual disability (ID) (N=171) 
Characteristic  With ID (N=142) Without ID (N=29) 
Age categories 
     0 - 4 
     5 - 9 
     10 - 14 
     15 – 19 














     Female 








     Qatari 








     Yes 
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Characteristic  With ID (N=142) Without ID (N=29) 
No. of family proband 
     Single 
     Extended (2 proband) 










     <10.000 
     10.000-20.000 









Mode of delivery 
     NVD 
     C-Section 
     Forceps/Suction 












     Yes 
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Characteristic  With ID (N=142) Without ID (N=29) 
Head Trauma 
     Yes 








     Yes 








     Verbal 
     Delayed 











4.2.6 Univariable analysis: Intellectual Disability 
Data was analyzed using univariable logistic regression analysis to select potential 
candidate variables to include in the multivariable logistic regression analysis. Based 
on the pre-set p-value criteria cut off point ≤0.25, age, nationality, number of the 
family probands, monthly income, mode of delivery, feeding practice, language and 
the postnatal and prenatal factors don’t enter the adjusted model. The univariable 
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logistic regression showed that gender was significantly associated with ID (p-value= 
0.150) (Table 12).  
Consanguinity was entered in the model because it is our main exposure. 
Additionally, based on clinical significance we included neonatal jaundice, although it 
was not significant in the univariable model. Despite that history of head trauma is a 
known risk factor for ID, we did not include it in the adjusted model because less than 




Table 12  
Crude association between ID and potential risk factors (Univariable logistic 
regression analysis) 
Variable OR 95% CI  P value 
Age categories 
     0 - 4 
     5 - 9 
     10 - 14 
     15 – 19 









0.08 – 11.14 
0.31 – 3.62 
0.92 – 16.01 
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Variable OR 95% CI  P value 
Gender 
     Male 














      Qatari 









     Yes 









No. of family proband 
     Single 
     Extended (2 proband) 






0.04 – 4.66 







Monthly income (QR) 
     <10.000 
     10.000 – 20.000 







0.19 – 1.72 
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Variable OR 95% CI  P value 
Mode of delivery 
     C-Section 
     Forceps/Suction 
     Protracted/Induced 














       Delayed 
     Non-verbal 






0.31 – 2.40 







    Yes 











     Yes 
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Variable OR 95% CI  P value 
Head Trauma 
     Yes 












4.2.7 Multivariable analysis: Intellectual Disability 
In the multivariable logistics regression model (adjusted model) none of the variables 
were statistically significantly associated with ID (Table 13). The odds of having ID 
increased by 50% among those whose parents were consanguineous (OR = 1.5; 95% 
CI: 0.62 – 3.52). History of neonatal jaundice was associated with 2 times odds of 
having ID (OR = 2; 95% CI: 0.43 –9.30). However male gender showed to decrease 
the odds having ID by 61% (OR 0.39; 95% CI: 0.11-1.40). As none of the variables 
were statistically significantly, we will report the univariable analysis.  
For confounding assessment, we enter the variables that we removed from the full 
model separately (gender, nationality, number of family proband, monthly income, 
mode of delivery and language and hypoxia) we found that the coefficient did not 
change by 15-20%, so we conclude that they were not confounders. Hosmer and 
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Table 13  
Adjusted association between ID and potential risk factors (multivariable logistic 
regression analysis) 
Variable OR 95% CI                           P value 
Gender 
     Male 









     Yes 









Neonatal jaundice  
     Yes 
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Chapter 5: Discussion 
5.1 The Meta-analysis 
To our knowledge, this is the first meta-analysis that studied the prevalence of 
consanguinity worldwide. Consanguinity has been reported to have severe effects on 
fetal growth and development, increasing the risk of congenital malformations 
(Kulkarni & Kurian, 1990). In addition, children born to consanguineous parents have 
been reported to have lower social behavior (Md Afzal & Sinha, 1983) and cognitive 
ability (Mohammad Afzal, 1988), which are the main problems with ASD children. 
Our study qualitatively reviewed the prevalence of consanguinity among ASD 
patients throughout the world and 10 eligible studies from eight countries were 
identified. We quantitatively synthesized the results and the key findings of this study 
showed a 24% overall pooled estimate of consanguinity among ASD patients. GCC 
countries showed a high estimated pooled prevalence of consanguinity among ASD 
patients as 38% compared to countries other than GCC 16%, which was higher than 
our overall pooled prevalence. This high estimate among GCC countries can be 
related to the high rates of consanguineous marriage in the GCC countries compared 
to the worldwide rates (20%) (Tadmouri et al., 2009). In Qatar the rate of 
consanguineous marriage reported as 54% (Bener & Hussain, 2006), while it was 
50.5% in United Arabs Emirates (al-Gazali et al., 1997), 56.3% in Oman and 39-45 % 
in Bahrain (Tadmouri et al., 2009). This high rates may be due to factors like rooted 
cultural beliefs, social life and customs in addition to, economic benefits of keeping 
wealth within the families, as reported by (Bener & Hussain, 2006).  
The overall odd ratio calculated from the case-control studies included in our meta-
analysis was 1.5 indicating a 50% increase in odds of having ASD among those 
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whose parents are related. We calculated the odd ratio from Adnan et al, 2014 which 
was the only study from the GCC to report the consanguinity prevalence among ASD 
cases and controls. The estimated odd ratio was 2.6 which was the highest odd ratio 
after that reported by Madhu P. Mamidala et al, 2015 (3.2).  
5.2 Cross-sectional study 
Consanguinity is high in the GCC and Middle East communities. In Qatar, the overall 
prevalence of consanguineous marriages is 55%. Al - Salehi and colleagues found in a 
Saudi Arabia study that nearly one - third of a cohort of children with autism had a 
history of consanguinity among their parents. Another study in Saudi Arabia reported 
that 55% of their subjects were outcome of consanguineous marriage. In India, Madhu 
P. Mamidala et al, 2015 demonstrate consanguinity prevalence as 20% of their ASD 
cases. Consanguinity among our sample was reported by 40% of the ASD cases 
families. Despite that this high prevalence did not provide proof of a direct relation 
between consanguinity and autism in Qatar. The high prevalence of consanguinity in 
Qatar, in addition to the rate of family history of autistic disorder among siblings 
supports the role of genetic factors in certain Qatari families, which other studies have 
suggested. 
Male predominance (79.5%) among subjects was observed. Similar to other research 
findings; gender ratios showing higher male predominance over female is the most 
constant joint finding in autism spectrum conditions studies (approximately 4:1). This 
could be due to genetic gender differences or based on the characteristics of male 
behavior; the criteria used to diagnose autism. 
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Earlier studies showed a higher risk of having autistic siblings for children with 
autism. Ozonoff et al., 2011, reported family rates of more than one person with ASD 
ranging from 3% to 18%. In our cohort, 17% of the families have 2 probands and 12% 
have more than two. Similar findings were reported by Farida El-Baz et al, 2011 with 
16% of their cohort have a family history of autism.  
Autistic children range from 0 to 60 in the IQ spectrum. In our cohort, 83% of the 
patients were in ID range with approximately half of the patients (48.5%) had 
moderate ID (IQ 36-51). This high percentage of ID among this cohort may be due to 
that most high-performance ASD cases in Qatar attend mainstream schools. About 
48% of families were in the highest income group (>20,000 QR per month), which 
was similar to that reported by Farida El-Baz et al, 2011 (48%). Regarding language 
development, most of the cases were nonverbal (48%), 28.6 % were delayed and 
23.4% were verbal.   
Epilepsy has been reported to be one of the negative cognitive, adaptive and 
behavioral factors for people with autism. The rate of epilepsy among ASD cases 
reported in most developed - country autism studies was 30-40% (Muhle, Trentacoste 
& Rapin, 2004). Bolton et al, 2011 studied epilepsy’s features and correlates in 150 
ASD individuals. 22% of participants developed epilepsy. Gender (female), 
intellectual disability and poorer verbal abilities were associated with epilepsy. 
Although the occurrence of epilepsy in probands in their families was not associated 
with a high risk of epilepsy, it was linked with the occurrence of the broader 
phenotype of autism in relatives. This proposes that family liability for autism was 
linked to the risk of epilepsy Our results showed a rate of epilepsy of 19%, which was 
close to that reported by in Saudi Arabia (22.4%). 
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No other studies looked at association between consanguinity and both epilepsy and 
ID Despite that, the univariable logistic regression analysis revealed that the odd ratio 
of having epilepsy and ID increased by consanguinity (OR 1.6 both), the association 
between epilepsy and ID among ASD patients and consanguinity was not statistically 
significant (P value >0.05) controlling for other potential risk factors. This may be 
due to the small number of subjects enrolled in this study and the fact that all the 
study subjects were recruited from one special needs center. These high odd ratios of 
having epilepsy and ID among consanguineous ASD patients might have a clinical 
significance, thus further research with large and more representative sample is 
needed to investigate this association. 
5.3 Limitation: 
5.3.1 Meta-analysis 
 Our study has some limitations, there was no enough reported studies worldwide we 
only found 10 studies on consanguinity prevalence among the ASD children from 
eight countries from Middle East and Asia regions. There were no studies reporting 
consanguinity prevalence among ASD individuals from other world regions as 
consanguineous marriages in these regions is very low as cited by Bittles AH, Black 
ML. Moreover, despite higher prevalence of consanguinity in the GCC countries only 
4 studies reported the consanguinity prevalence among the ASD. Despite that male 
predominance in ASD was stated by many studies, we couldn’t assess the relation 
between consanguinity and gender as consanguinity prevalence reported in the 
included studies as the overall prevalence and was not reported by gender. 
After assessing the quality of the studies most of the studies have low to moderate risk 
of bias, but with higher risk to the external validity because 50% of studies rated 
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poorly for having a random assignment of the sample population. There was 
considerable significant heterogeneity among the articles, it present major threat to the 
pooled estimate as indicated by large confidence interval in our estimates. However, 
this is the first study that attempt to pool the prevalence of consanguinity among ASD 
individuals worldwide and this study should be updated after more and high-quality 
studies are published. 
5.3.2 Cross sectional 
Some limitations of this study were the lack of comparable data and unavailability of 
some data such as rates of obstetric complications. The small sample size included in 
this study as well as the nationality distribution in our study indicated that almost half 
of them are Qatari which is not reflective of the estimated 2.6 million live in Qatar. 
This is expected as more Qataris get enrolled to these schools. 
Additionally, the nature of the study as analysis of cross-sectional data Ideally, we 
cannot guarantee the data to be representative.  
Furthermore, the models that were developed were multivariable logistic regression 
purposive selection favoring clinical consideration, but we stop at the preliminary 
main effect model due to all the predictors were statistically insignificant. Finally, 










More and highly quality epidemiological studies worldwide especially at the GCC 
countries are required to estimate the prevalence of consanguinity among ASD 
individuals and identify the high prevalence countries. These studies should pay 
attention to external validity because most of them rarely randomized their samples. 
Larger randomly selected patients would give rise to much more precise and accurate 
estimates that will reflect in smaller confidence intervals in the meta analytical 
estimates. 
Regarding the association between consanguinity with epilepsy and intellectual 
disability among ASD individuals, additional studies with more sample size, 
variability and representativeness are necessary to confirm our results.  
  




To our knowledge, this is the first meta-analysis that studied the prevalence of 
consanguinity worldwide. The globally estimated pooled consanguinity prevalence 
among ASD patients was 24%, GCC countries showed a higher pooled prevalence 
(38%). No studies looked at association between consanguinity and both epilepsy and 
ID. The clinical sample used did not provide any evidence on association between 
both epilepsy and ID and consanguinity among ASD patients in Qatar. These high 
odd ratios of having epilepsy and ID among consanguineous ASD patients might have 
a clinical significance, thus further research with large and more representative 
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Stata do file commands 
*****Thesis Data Do file***** 
**Descriptive Analysis** 
describe 
tabstat age , statistics( mean sd count ) 
//Epilepsy (outcome 1) 
tab epi 
tabstat age, statistics( mean sd count ) by( epi ) 
tab age epi ,chi2 row 
tab gender epi ,chi2 row 
tab fpro epi ,chi2 row  
tab nation epi ,chi2 row   
tab mi epi ,chi2 row  
tab consang epi ,chi2 row  
tab mod epi ,chi2 row  
tab lang epi ,chi2 row 
tab nj epi ,chi2 row  
tab hypoxia epi ,chi2 row  
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tab htr epi ,chi2 row 
*********************************************************************
* 
 *//Univariate Analysis 
logit epilepsy i.age ,nolog or  
logit epilepsy i.sex ,nolog or 
logit epilepsy i.nationality ,nolog or  
logit epilepsy i.familyprobands ,nolog or  
logit epilepsy i.monthlyincome ,nolog or  
logit epilepsy i.consanguinty ,nolog or // include 0.220 
logit epilepsy i.modeofdelivery ,nolog or  
logit epilepsy i.verbal ,nolog or 
test 1.verbal 2.verbal 
logit epilepsy i.hypoxia ,nolog or  
logit epilepsy i.headtrauma ,nolog or  




//Multi variable analysis for the epilepsy 
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logit epilepsy i.age i.sex i.consanguinty i.hypoxia i.neonataljaundice,nolog or 
//Based on the sig 0.25 only consaguinity enter the model,and based on clinical  




 // Descriptive Analysis (intellectual disability) 
tab id 
recode id 2=1 3=1 
tab age id ,chi2 row 
tab sex id ,chi2 row  
tab nationality id ,chi2 row  
tab familyprobands id ,chi2 row  
tab monthlyincome id ,chi2 row  
tab consanguinty id ,chi2 row   
tab modeofdelivery id ,chi2 row  
tab verbal id ,chi2 row  
tab hypoxia id ,chi2 row  
tab neonataljaundice id ,chi2 row  
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tab headtrauma id ,chi2 row  
********************************************************************* 
*//Univariate Analysis 
logit id i.age ,nolog or  
logit id i.sex ,nolog or // Pvalue=0.150 
logit id i.nationality ,nolog or  
logit id i.consanguinty ,nolog or  
logit id i.familyprobands ,nolog or 
logit id i.monthlyincome ,nolog or 
logit id i.modeofdelivery ,nolog or 
logit id i.verbal ,nolog or 
logit id i.neonataljaundice ,nolog or 
logit id i.hypoxia ,nolog or 
*********************************************************************
* 
//Multi variablr model of the ID  
//Based on p value 2 var enter the full model (sex, consanguinity) 
//based on clinical sig 2 var enter the model(neonatal jaundice) 
logit id i.sex i.consanguinty i.neonataljaundice,nolog or 
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